These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 15218240)
21. Molecular heterogeneity in human papillomavirus-dependent and -independent vulvar carcinogenesis. Swarts DRA; Voorham QJM; van Splunter AP; Wilting SM; Sie D; Pronk D; van Beurden M; Heideman DAM; Snijders PJF; Meijer CJLM; Steenbergen RDM; Bleeker MCG Cancer Med; 2018 Sep; 7(9):4542-4553. PubMed ID: 30030907 [TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study. Hildesheim A; Han CL; Brinton LA; Kurman RJ; Schiller JT Obstet Gynecol; 1997 Nov; 90(5):748-54. PubMed ID: 9351758 [TBL] [Abstract][Full Text] [Related]
23. Genetic changes during the multistage pathogenesis of human papillomavirus positive and negative vulvar carcinomas. Flowers LC; Wistuba II; Scurry J; Muller CY; Ashfaq R; Miller DS; Minna JD; Gazdar AF J Soc Gynecol Investig; 1999; 6(4):213-21. PubMed ID: 10486784 [TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma. Rosenthal AN; Hopster D; Ryan A; Jacobs IJ Br J Cancer; 2003 Jan; 88(2):251-6. PubMed ID: 12610510 [TBL] [Abstract][Full Text] [Related]
25. Characterization of 10 vulvar carcinoma cell lines by karyotyping, comparative genomic hybridization and flow cytometry. Raitanen M; Worsham MJ; Lakkala T; Carey TE; Van Dyke DL; Grénman R; Klemi P; Rantanen V; Isola J; Grénman S Gynecol Oncol; 2004 Apr; 93(1):155-63. PubMed ID: 15047230 [TBL] [Abstract][Full Text] [Related]
26. Aberrant promoter methylation of SH3GL2 gene in vulvar squamous cell carcinoma correlates with clinicopathological characteristics and HPV infection status. Li B; He Y; Han X; Zhang S; Xu Y; Zhou Y; Song Z; Ouyang L Int J Clin Exp Pathol; 2015; 8(11):15442-7. PubMed ID: 26823912 [TBL] [Abstract][Full Text] [Related]
27. Expression of epithelial growth factor receptor and its two ligands, transforming growth factor-alpha and epithelial growth factor, in normal and neoplastic squamous cells in the vulva: an immunohistochemical study. Wu X; Xin Y; Yao J; Hasui K; Tsuyama S; Yonezawa S; Murata F Med Electron Microsc; 2001 Sep; 34(3):179-84. PubMed ID: 11793194 [TBL] [Abstract][Full Text] [Related]
28. HPV-negative vulvar intraepithelial neoplasia (VIN) with basaloid histologic pattern: an unrecognized variant of simplex (differentiated) VIN. Ordi J; Alejo M; Fusté V; Lloveras B; Del Pino M; Alonso I; Torné A Am J Surg Pathol; 2009 Nov; 33(11):1659-65. PubMed ID: 19730361 [TBL] [Abstract][Full Text] [Related]
29. Presence and type of oncogenic human papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma. Bonvicini F; Venturoli S; Ambretti S; Paterini P; Santini D; Ceccarelli C; Zerbini M; Musiani M J Med Virol; 2005 Sep; 77(1):102-6. PubMed ID: 16032717 [TBL] [Abstract][Full Text] [Related]
31. Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva. Faber MT; Sand FL; Albieri V; Norrild B; Kjaer SK; Verdoodt F Int J Cancer; 2017 Sep; 141(6):1161-1169. PubMed ID: 28577297 [TBL] [Abstract][Full Text] [Related]
32. HPV status and favourable outcome in vulvar squamous cancer. Wakeham K; Kavanagh K; Cuschieri K; Millan D; Pollock KG; Bell S; Burton K; Reed NS; Graham SV Int J Cancer; 2017 Mar; 140(5):1134-1146. PubMed ID: 27864932 [TBL] [Abstract][Full Text] [Related]
33. Allelic loss in human papillomavirus-positive and -negative vulvar squamous cell carcinomas. Pinto AP; Lin MC; Mutter GL; Sun D; Villa LL; Crum CP Am J Pathol; 1999 Apr; 154(4):1009-15. PubMed ID: 10233839 [TBL] [Abstract][Full Text] [Related]
34. Molecular events in the pathogenesis of vulvar squamous cell carcinoma. Xing D; Fadare O Semin Diagn Pathol; 2021 Jan; 38(1):50-61. PubMed ID: 33032902 [TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus, Epstein-Barr virus and p53 mutation in vulvar intraepithelial neoplasia. Almeida G; do Val I; Gondim C; Lima R; Takiya C; Carvalho G J Reprod Med; 2004 Oct; 49(10):796-9. PubMed ID: 15568402 [TBL] [Abstract][Full Text] [Related]
36. Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus-positive and -negative tumors. Dahlgren L; Mellin H; Wangsa D; Heselmeyer-Haddad K; Björnestål L; Lindholm J; Munck-Wikland E; Auer G; Ried T; Dalianis T Int J Cancer; 2003 Nov; 107(2):244-9. PubMed ID: 12949801 [TBL] [Abstract][Full Text] [Related]
37. Allelic imbalance in lichen sclerosus, hyperplasia, and intraepithelial neoplasia of the vulva. Pinto AP; Lin MC; Sheets EE; Muto MG; Sun D; Crum CP Gynecol Oncol; 2000 Apr; 77(1):171-6. PubMed ID: 10739707 [TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus infections in vulvar precancerous lesions and cancer. Costa S; Syrjänen S; Vendra C; Chang F; Guida G; Hippeläinen M; Terzano P; Tervahauta A; Yliskoski M; Syrjänen K J Reprod Med; 1995 Apr; 40(4):291-8. PubMed ID: 7623359 [TBL] [Abstract][Full Text] [Related]
39. p53 codon 72 polymorphism in vulval cancer and vulval intraepithelial neoplasia. Rosenthal AN; Ryan A; Hopster D; Jacobs IJ Br J Cancer; 2000 Nov; 83(10):1287-90. PubMed ID: 11044351 [TBL] [Abstract][Full Text] [Related]